See more : Emperor Entertainment Hotel Limited (0296.HK) Income Statement Analysis – Financial Results
Complete financial analysis of Optima Medical Innovations Corp. (OMIC.CN) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Optima Medical Innovations Corp., a leading company in the Medical – Care Facilities industry within the Healthcare sector.
- Minnova Corp. (MCI.V) Income Statement Analysis – Financial Results
- Sunwave Communications Co.Ltd (002115.SZ) Income Statement Analysis – Financial Results
- Jiangxi Jovo Energy Co., Ltd (605090.SS) Income Statement Analysis – Financial Results
- Hope, Inc. (6195.T) Income Statement Analysis – Financial Results
- Nordstrom, Inc. (0K8J.L) Income Statement Analysis – Financial Results
Optima Medical Innovations Corp. (OMIC.CN)
About Optima Medical Innovations Corp.
Optima Medical Innovations Corp. produces and sells hemp-based cannabidiol (CBD) products in Canada and internationally. It offers industrial hemp-derived CBD oil, airless metered pens, capsules, topicals, and tinctures. The company also operates multidisciplinary pain clinics, which focuses on the treatment of chronic pain, including comprehensive, medical, and interventional pain management; independent medical evaluations; physiotherapy and chiropractic care; and medical cannabis and platelet rich plasma therapy, as well as mindfulness teaching. It has a research agreement with the Ryerson University for medical cannabis research and new medical grade products development. The company was formerly known as Tree of Knowledge International Corp. and changed its name to Optima Medical Innovations Corp. in November 2021. Optima Medical Innovations Corp. is based in Toronto, Canada.
| Metric | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 4.61M | 5.50M | 694.89K | 710.00 | 631.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 725.43K | 0.00 | 0.00 |
| Cost of Revenue | 5.82M | 9.68M | 6.56M | 256.57 | 444.30 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | -1.21M | -4.18M | -5.87M | 453.43 | 186.70 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 725.43K | 0.00 | 0.00 |
| Gross Profit Ratio | -26.25% | -76.15% | -844.48% | 63.86% | 29.59% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 100.00% | 0.00% | 0.00% |
| Research & Development | 103.01K | 33.74K | 63.58K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 21.75K | 0.00 |
| General & Administrative | 2.88M | 7.29M | 7.52M | 106.06K | 46.70K | 149.10K | 185.99K | 193.52K | 154.12K | 213.10K | 1.64M | 151.06K | 104.44K |
| Selling & Marketing | 0.00 | -4.41M | -6.06M | 0.00 | 42.76K | 319.69K | 28.50K | 0.00 | 0.00 | 0.00 | 75.61K | 61.32K | 0.00 |
| SG&A | 2.88M | 2.88M | 1.46M | 106.06K | 89.46K | 468.79K | 214.48K | 193.52K | 154.12K | 213.10K | 1.72M | 151.06K | 104.44K |
| Other Expenses | 0.00 | 0.00 | -1.53M | -29.45K | -44.19K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 1.38M | 2.91M | 1.53M | 106.06K | 89.46K | 468.79K | 214.48K | 193.52K | 154.12K | 213.10K | 2.09M | 151.06K | 104.44K |
| Cost & Expenses | 7.27M | 12.59M | 8.09M | 106.06K | 89.46K | 468.79K | 214.48K | 193.52K | 154.12K | 213.10K | 2.09M | 151.06K | 104.44K |
| Interest Income | 603.00 | 21.49K | 0.00 | 0.00 | 631.00 | 18.07K | 20.17K | 16.05K | 13.20K | 10.20K | 0.00 | 0.00 | 0.00 |
| Interest Expense | 520.80K | 225.33K | 6.34K | 2.79K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 41.86K | 155.13K | 0.00 |
| Depreciation & Amortization | 691.23K | 1.35M | 169.86K | 65.81 | 38.14 | 0.00 | 0.00 | 97.83K | 115.66K | 128.50K | 231.69K | 152.96K | 36.84K |
| EBITDA | -2.89M | -16.46M | -13.79M | -134.79K | -46.07K | -468.79K | -214.48K | -136.58K | -89.69K | -140.58K | -1.13M | -1.48M | -669.14K |
| EBITDA Ratio | -62.73% | -104.55% | -1,039.95% | -18,984.65% | -14,177.65% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -155.71% | 0.00% | 0.00% |
| Operating Income | -2.25M | -7.10M | -7.40M | -5.62K | -89.46K | -468.79K | -214.48K | -234.42K | -205.35K | -269.08K | -1.36M | -151.06K | -141.29K |
| Operating Income Ratio | -48.79% | -129.19% | -1,064.40% | -790.87% | -14,177.65% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -187.64% | 0.00% | 0.00% |
| Total Other Income/Expenses | -1.92M | -10.47M | -6.57M | -32.24K | -42.77K | 18.33K | 18.12K | 0.00 | 0.00 | -6.34K | -41.86K | 0.00 | -709.13K |
| Income Before Tax | -4.17M | -18.04M | -13.97M | -137.58K | -88.84K | -450.46K | -196.36K | -234.42K | -205.35K | -275.42K | -1.40M | -151.06K | -141.29K |
| Income Before Tax Ratio | -90.39% | -328.33% | -2,009.80% | -19,377.75% | -14,078.92% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -193.42% | 0.00% | 0.00% |
| Income Tax Expense | -636.81 | -21.49K | 936.75K | -26.72K | -38.27 | 0.00 | 0.00 | -56.94K | -64.43K | -66.19K | 0.00 | 790.39K | 0.58 |
| Net Income | -3.96M | -18.04M | -14.90M | -137.58K | -88.84K | -450.46K | -196.36K | -234.42K | -205.35K | -275.42K | -1.40M | -1.67M | -141.29K |
| Net Income Ratio | -85.86% | -328.33% | -2,144.60% | -19,377.75% | -14,078.92% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -193.42% | 0.00% | 0.00% |
| EPS | 0.00 | -0.42 | -1.04 | 0.00 | 0.00 | -0.02 | -0.01 | 0.00 | 0.00 | 0.00 | -0.02 | -0.07 | -0.04 |
| EPS Diluted | 0.00 | -0.42 | -1.04 | 0.00 | 0.00 | -0.02 | -0.01 | 0.00 | 0.00 | 0.00 | -0.02 | -0.07 | -0.04 |
| Weighted Avg Shares Out | 243.25M | 43.01M | 14.27M | 117.32M | 23.46M | 23.46M | 23.46M | 107.04M | 102.07M | 101.74M | 65.40M | 22.91M | 3.26M |
| Weighted Avg Shares Out (Dil) | 243.25M | 43.01M | 14.27M | 117.32M | 23.46M | 23.46M | 23.46M | 107.04M | 102.07M | 101.74M | 65.40M | 22.91M | 3.26M |
Source: https://incomestatements.info
Category: Stock Reports